Search research articles
Contact Us
Filters
Showing results (11-20 of 77) with videos related to
Page
of 8
Sort By:
CPT: Pharmacometrics & Systems Pharmacology
|
September 29, 2023
Skipping a pillar does not make for strong foundations: Pharmacokinetic-pharmacodynamic reasoning behind the shape of dose-response relationships in oncology
James W T Yates, Hitesh B Mistry
Cancer Research
|
October 3, 2019
Quantifying Preexisting Resistant and Persister Populations-Letter
Hitesh B Mistry, James W T Yates
Computer Methods and Programs in Biomedicine
|
January 17, 2012
Estimating insulin sensitivity from glucose levels only: Use of a non-linear mixed effects approach and maximum a posteriori (MAP) estimation
James W T Yates, Edmund M Watson
Clinical and Translational Science
|
October 30, 2021
How translational modeling in oncology needs to get the mechanism just right
James W T Yates, David A Fairman
European Journal of Cancer (Oxford, England : 1990)
|
April 23, 2021
A meta-analysis of tumour response and relapse kinetics based on 34,881 patients: A question of cancer type, treatment and line of treatment
James W T Yates, S Y Amy Cheung
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
December 19, 2015
Designing More Efficient Preclinical Experiments: A Simulation Study in Chemotherapy-Induced Myelosupression
Emma C Martin, Leon Aarons, James W T Yates
Journal of Biological Dynamics
|
April 11, 2022
Comparison of classical tumour growth models for patient derived and cell-line derived xenografts using the nonlinear mixed-effects framework
Dimitrios Voulgarelis, Krishna C Bulusu, James W T Yates
International Journal of Antimicrobial Agents
|
July 25, 2022
The ingredients for an antimicrobial mathematical modelling broth
Marcus Tindall, Michael J Chappell, James W T Yates
Cancer Chemotherapy and Pharmacology
|
May 26, 2016
Accounting for dropout in xenografted tumour efficacy studies: integrated endpoint analysis, reduced bias and better use of animals
Emma C Martin, Leon Aarons, James W T Yates
Cancer Chemotherapy and Pharmacology
|
July 29, 2018
Pharmacodynamic modelling of resistance to epidermal growth factor receptor inhibition in brain metastasis mouse models
Emma C Martin, Leon Aarons, James W T Yates
Page
of 8
Search research articles
Search
Showing results (11-20 of 77) with videos related to
Sort By:
Page
of 8
CPT: Pharmacometrics & Systems Pharmacology
|
September 29, 2023
Skipping a pillar does not make for strong foundations: Pharmacokinetic-pharmacodynamic reasoning behind the shape of dose-response relationships in oncology
James W T Yates, Hitesh B Mistry
Cancer Research
|
October 3, 2019
Quantifying Preexisting Resistant and Persister Populations-Letter
Hitesh B Mistry, James W T Yates
Computer Methods and Programs in Biomedicine
|
January 17, 2012
Estimating insulin sensitivity from glucose levels only: Use of a non-linear mixed effects approach and maximum a posteriori (MAP) estimation
James W T Yates, Edmund M Watson
Clinical and Translational Science
|
October 30, 2021
How translational modeling in oncology needs to get the mechanism just right
James W T Yates, David A Fairman
European Journal of Cancer (Oxford, England : 1990)
|
April 23, 2021
A meta-analysis of tumour response and relapse kinetics based on 34,881 patients: A question of cancer type, treatment and line of treatment
James W T Yates, S Y Amy Cheung
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
December 19, 2015
Designing More Efficient Preclinical Experiments: A Simulation Study in Chemotherapy-Induced Myelosupression
Emma C Martin, Leon Aarons, James W T Yates
Journal of Biological Dynamics
|
April 11, 2022
Comparison of classical tumour growth models for patient derived and cell-line derived xenografts using the nonlinear mixed-effects framework
Dimitrios Voulgarelis, Krishna C Bulusu, James W T Yates
International Journal of Antimicrobial Agents
|
July 25, 2022
The ingredients for an antimicrobial mathematical modelling broth
Marcus Tindall, Michael J Chappell, James W T Yates
Cancer Chemotherapy and Pharmacology
|
May 26, 2016
Accounting for dropout in xenografted tumour efficacy studies: integrated endpoint analysis, reduced bias and better use of animals
Emma C Martin, Leon Aarons, James W T Yates
Cancer Chemotherapy and Pharmacology
|
July 29, 2018
Pharmacodynamic modelling of resistance to epidermal growth factor receptor inhibition in brain metastasis mouse models
Emma C Martin, Leon Aarons, James W T Yates
Page
of 8